Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer's disease. - Wikidata - wikimedia - TriplyDB

Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer's disease.

Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer's disease.

http://www.wikidata.org/entity/Q33670207

about

Extracellular Vesicles and a Novel Form of Communication in the Brain Focus on Extracellular Vesicles: Exosomes and Their Role in Protein Trafficking and Biomarker Potential in Alzheimer's and Parkinson's Disease Myeloid Extracellular Vesicles: Messengers from the Demented Brain Exosomes as Novel Regulators of Adult Neurogenic Niches Roles and regulation of neutral sphingomyelinase-2 in cellular and pathological processes Accumulation of amyloid-β by astrocytes result in enlarged endosomes and microvesicle-induced apoptosis of neurons Microglia communication: Parallels between aging and Alzheimer's disease Ceramides in Alzheimer's Disease: Key Mediators of Neuronal Apoptosis Induced by Oxidative Stress and Aβ Accumulation Neutral Sphingomyelinase-2 Deficiency Ameliorates Alzheimer's Disease Pathology and Improves Cognition in the 5XFAD Mouse Guggulsterone and bexarotene induce secretion of exosome-associated breast cancer resistance protein and reduce doxorubicin resistance in MDA-MB-231 cells Endothelial Cells Can Regulate Smooth Muscle Cells in Contractile Phenotype through the miR-206/ARF6&NCX1/Exosome Axis.Extracellular vesicles and their synthetic analogues in aging and age-associated brain diseases.The 5XFAD Mouse Model of Alzheimer's Disease Exhibits an Age-Dependent Increase in Anti-Ceramide IgG and Exogenous Administration of Ceramide Further Increases Anti-Ceramide Titers and Amyloid Plaque Burden.Exosomes as a Nanodelivery System: a Key to the Future of Neuromedicine?Extracellular vesicles of the blood-brain barrier.Extracellular Vesicles Isolated from the Brains of rTg4510 Mice Seed Tau Protein Aggregation in a Threshold-dependent Manner.A critical role of cardiac fibroblast-derived exosomes in activating renin angiotensin system in cardiomyocytes.Exosomes derived from mature dendritic cells increase endothelial inflammation and atherosclerosis via membrane TNF-α mediated NF-κB pathway.Exosomes, an Unmasked Culprit in Neurodegenerative Diseases.Plasma Exosomes Spread and Cluster Around β-Amyloid Plaques in an Animal Model of Alzheimer's Disease.The role of exosomes in the pathogenesis of Alzheimer' disease.Amyloid plaque structure and cell surface interactions of β-amyloid fibrils revealed by electron tomography.Microglial-derived microparticles mediate neuroinflammation after traumatic brain injury.Exosomes in the Diseased Brain: First Insights from In vivo Studies.Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells.Extracellular vesicles in Alzheimer's disease: friends or foes? Focus on aβ-vesicle interaction.Metabolic Modifications in Human Biofluids Suggest the Involvement of Sphingolipid, Antioxidant, and Glutamate Metabolism in Alzheimer's Disease Pathogenesis.Role of sphingomyelinases in neurological disorders.Enhanced exosome secretion in Down syndrome brain - a protective mechanism to alleviate neuronal endosomal abnormalities.Are exosomes the vehicle for protein aggregate propagation in neurodegenerative diseases?Increased Release of Apolipoprotein E in Extracellular Vesicles Following Amyloid-β Protofibril Exposure of Neuroglial Co-Cultures.Physiological and pathological impact of exosomes of adipose tissue.Exosome secretion is a key pathway for clearance of pathological TDP-43.Modulation of Neuroinflammation in the Central Nervous System: Role of Chemokines and Sphingolipids.Study of Exosomes Shed New Light on Physiology of Amyloidogenesis.Exosomes in stroke pathogenesis and therapy.Extracellular vesicles and intercellular communication within the nervous system.Exosomal cellular prion protein drives fibrillization of amyloid beta and counteracts amyloid beta-mediated neurotoxicity.Sphingolipid-Enriched Extracellular Vesicles and Alzheimer's Disease: A Decade of Research.Functions of Exosomes and Microbial Extracellular Vesicles in Allergy and Contact and Delayed-Type Hypersensitivity.

P2860

Q26750015-62703245-4C1B-4605-BCA9-5C1BBA4859D9 Q26767264-81852F1A-7202-4334-B25C-AE939C7414CB Q26767455-FCB272EB-A3FB-4E4F-8EB0-A88711AE0FA2 Q26772836-01ED482E-8138-4E22-BBF0-D2BB6937418D Q27022944-AC40530F-2FEC-444A-9B09-05BB16ED9768 Q27301082-BEC633D2-39FF-4040-9303-2901C12CFDB0 Q28074099-80085FEB-DF76-4221-B878-9D5D2B9AFD29 Q28087030-476786D3-B5C0-47EC-BCA5-2BF993D77752 Q30363059-EF34C156-14F3-402C-A070-ADDC40951EAC Q35592570-7D080593-35B1-416F-950E-B40AFCBD1B6C Q35975556-F68D9C55-4B99-44EF-89EC-8D41D0B0DBF9 Q36081720-D63E66D3-47B4-4BA9-ADF1-9C825107C4B1 Q36121819-29B0EBEF-6628-47AD-8A62-7FCED9A28A08 Q36577074-B47586A3-5762-4D0D-8BDE-34E6A69B1DD8 Q36812442-BD9AA0DF-F09B-4F2C-9734-C54E887AA862 Q37066447-3D27001C-2402-400A-BF33-DDCC7D019E3A Q37182864-8DE01231-25AA-4221-BBCF-2FC5606D075D Q37466791-AC8729CD-83F0-41BC-A9F8-43A67FEEB6FE Q37614565-7C36D121-5B00-4540-92D2-692B44BF4C68 Q37617386-32498823-2172-4DF1-B6A3-573698377306 Q37621060-B8DF8B4C-94EA-4549-9F27-1BCCA97D4F73 Q37668087-4D478B26-A329-4E5E-AFF3-C334E424F61E Q37700810-FD2EC647-6143-4F0E-BCB8-6BA2198FC4C9 Q37716769-DC07C7C1-D28E-4F6A-8FFB-CE4BE3EB4C5F Q37721155-86C3E377-E572-4EF9-86AE-164D625A016E Q38367860-A27148FA-A59D-4E45-A112-2DA04F3FDC4F Q38401864-11BCBE01-706F-419F-9BF7-B898077ED5B8 Q38560939-0B10F468-9F19-47BF-9BAF-C1DA246C0D38 Q38603319-5EB7E1B3-4F29-4FC0-8B97-45C18625DC5C Q38636003-A299E2AE-796F-4C92-AC5B-AE53AB0B9962 Q38639510-30C8209D-D4C7-43C6-A8DD-AE3BD5F28AA6 Q38699786-E1391A6E-1B81-4D6F-9DE9-C560F36FCAB9 Q38743399-5ADCE1DA-5509-4572-A211-144ED8FE0618 Q38774697-B77491DB-86A3-4497-83E4-A736BC3A4BD8 Q38777380-5DE54FA9-D165-4EDE-86FB-C24119122429 Q38795614-78CAFE48-4459-42D4-99A1-430F55E12637 Q38795618-2F87AFC0-2A72-4CB7-BDF8-656309BC55E6 Q38808517-7D8F0407-271B-4FC9-9D10-B41BDB3063F4 Q38962786-F83D3D0E-C2F5-476C-8561-39198B3CF53A Q39002019-A8C86E82-494A-4A3C-9D34-1F99DDB931BB

P2860

Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer's disease.

http://www.wikidata.org/entity/Q33670207

description

2014 nî lūn-bûn

@nan

2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Exosome reduction in vivo is a ...... model of Alzheimer's disease.

@ast

Exosome reduction in vivo is a ...... model of Alzheimer's disease.

@en

type

label

Exosome reduction in vivo is a ...... model of Alzheimer's disease.

@ast

Exosome reduction in vivo is a ...... model of Alzheimer's disease.

@en

prefLabel

Exosome reduction in vivo is a ...... model of Alzheimer's disease.

@ast

Exosome reduction in vivo is a ...... model of Alzheimer's disease.

@en

P1433

Q33670207-82EF8DAB-5A6A-4CA7-89B5-4E66F5436956

P1476

Q33670207-7785281E-FE0A-42EE-85FE-6D74D8D94B79

P2093

Q33670207-46764D93-5B54-4B30-9BCB-7C49B3F045D7

Q33670207-50844A6A-E285-4A64-9198-4B897A02C29C

Q33670207-58A56C67-0DC1-4023-AC91-8DA4C2BA2089

Q33670207-60EC06DE-D21B-4E36-B09A-2940AD582556

Q33670207-D3EBC844-FE2A-4842-9788-8BF9895A895C

P2860

Q33670207-01CE2F88-9EF7-4E68-8AF4-8BB42EC882C1

Q33670207-03650FC0-57F2-4B81-97E2-111772AD8AAE

Q33670207-0D57E424-8004-4532-88B9-C0D7A96C1A96

Q33670207-10CBF453-6FB1-4686-B43B-07289CC216C4

Q33670207-192C4465-A245-4663-ABC4-D60153FADFC0

Q33670207-1A26FE54-C18E-480F-A5A4-09117DFB5BCC

Q33670207-1CC55783-2697-42DA-AE25-A28033CF15D8

Q33670207-1FBD6EB5-089D-4611-94F1-95333380DA8B

Q33670207-21D100F3-5B00-4AAD-A2C6-630ED3522522

Q33670207-2565375C-8ADC-4240-981F-DC4B95076ACB

P304

Q33670207-E6BE5E84-8DF2-4C78-B14D-4B006FB12156

P31

Q33670207-D2252F4F-D3FC-454B-937D-D1F4A3642245

P356

Q33670207-AF66BA27-1439-4E0E-BAB5-EB8161B9DB58

P433

Q33670207-B2D1889B-1B76-43C9-ACAF-9C80E0E4E1C0

P478

Q33670207-81754334-2DE4-4D10-847B-C341AD9D0B6B

P577

Q33670207-990318C5-0FC7-4B30-A856-0BEABADDECFE

P698

Q33670207-CAEB527F-1B11-4202-995E-F443B09E3394

P921

Q33670207-1971D98B-3F37-4C97-B47C-42C63DEE096A

P932

Q33670207-341737E1-1C70-4790-8391-CF1BEEBD8D98

P356

J.NEUROBIOLAGING.2014.02.012

P1433

Neurobiology of Aging

P1476

Exosome reduction in vivo is a ...... model of Alzheimer's disease.

@en

P2093

Erhard Bieberich

http://www.w3.org/2001/XMLSchema#string

Gu Zhu

http://www.w3.org/2001/XMLSchema#string

Guanghu Wang

http://www.w3.org/2001/XMLSchema#string

Michael B Dinkins

http://www.w3.org/2001/XMLSchema#string

Somsankar Dasgupta

http://www.w3.org/2001/XMLSchema#string

P2860

Exosomes: vehicles for the transfer of toxic proteins associated with neurodegenerative diseases?

Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation

Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE

Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers

ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models

Statins promote the degradation of extracellular amyloid {beta}-peptide by microglia via stimulation of exosome-associated insulin-degrading enzyme (IDE) secretion

Regulation of neutral sphingomyelinase-2 by GSH: a new insight to the role of oxidative stress in aging-associated inflammation

Age-related changes in neutral sphingomyelin-specific phospholipase C activity in striatum, hippocampus, and frontal cortex: implication for sensitivity to stress and inflammation

MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response

Decreased clearance of CNS beta-amyloid in Alzheimer's disease

P304

1792-1800

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NEUROBIOLAGING.2014.02.012

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P577

2014-02-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24650793

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

4035236

http://www.w3.org/2001/XMLSchema#string